AbbVie selects Sterling Background Check for BackGround Screening

In 2020, AbbVie, a United States based Life Sciences organization with 55000 employees and revenues of $56.3B selected Sterling Background Check for BackGround Screening while displacing Legacy, and integrating with the existing systems being used.

Customer Vendor Old Product New Product Category Market Users VAR/SI When Live
AbbVie Sterling Talent Solutions Legacy Sterling Background Check BackGround Screening HCM n/a n/a 2020 2020
Discover the latest software purchases and digital transformation initiatives being undertaken by AbbVie and its business and technology executives by accessing the entire AbbVie and its business and technology executives by becoming a Premium Subscriber. On a continuous basis, our research team identifies and updates the on-prem and cloud applications that are being used by AbbVie employees from publicly available data (Press Releases, Customer References, Case Studies, Success Stories, Testimonials, RFP, RFI, etc.) as well as proprietary sources, and incorporate them into the customer profile.

Don't miss the entire: AbbVie Technographics profile

FAQ - AbbVie selects Sterling Background Check for (BackGround Screening)

In 2020, AbbVie selected Sterling Background Check for BackGround Screening to modernize their HCM operations and improve scalability, visibility, and control.

The Sterling Background Check deployment replaces Legacy and integrates with existing systems to streamline processes, reporting, and compliance across HCM.

AbbVie is a Life Sciences organization in United States, with approximately 55000 employees and $56.3B in annual revenue.

AbbVie has initiated the Sterling Background Check implementation with an expected go-live in 2020, supporting its modernization of BackGround Screening processes.

AbbVie has not disclosed the SI for the Sterling Background Check implementation.

Subscribe to APPS RUN THE WORLD to view the verified software purchases, implementation timelines, and related deployments.